By expenditures
| Name | Title | Type |
|---|---|---|
| Mark Bisson | Vice President For Business Affairs | Auditee |
| Sara Grenier | Partner | Auditee |
| Crystal Cheek | DIRECTOR OF FINANCE/COMPTROLLER | Auditee |
| Kirk Vanderslice | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 398877 | 2025 | 2026-04-15 | FORVIS MAZARS LLP | $44.52M |
| 341334 | 2024 | 2025-02-05 | Forvis Mazars LLP | $41.95M |
| 10849 | 2023 | 2024-01-10 | Hinkle & Company PC | $35.54M |
| 47715 | 2022 | 2022-12-29 | Hinkle& Company PC | $42.75M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 398877 | 2025 | 2026-04-15 | 1206882 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206881 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206880 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206879 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206878 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206877 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206876 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206875 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206874 | 2025-002 | Material Weakness | Yes | C |
| 398877 | 2025 | 2026-04-15 | 1206873 | 2025-002 | Material Weakness | Yes | N |
| 398877 | 2025 | 2026-04-15 | 1206872 | 2025-001 | Material Weakness | Yes | N |
| 398877 | 2025 | 2026-04-15 | 1206871 | 2025-001 | Material Weakness | Yes | N |
| 398877 | 2025 | 2026-04-15 | 1206870 | 2025-001 | Material Weakness | Yes | N |
| 398877 | 2025 | 2026-04-15 | 1206869 | 2025-001 | Material Weakness | Yes | N |
| 341334 | 2024 | 2025-02-05 | 1098559 | 2024-003 | Material Weakness | - | I |
| 341334 | 2024 | 2025-02-05 | 1098558 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 1098557 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 1098556 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 1098555 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 1098554 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 1098553 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 1098552 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 1098551 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 1098550 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 1098549 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 522117 | 2024-003 | Material Weakness | - | I |
| 341334 | 2024 | 2025-02-05 | 522116 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 522115 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 522114 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 522113 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 522112 | 2024-002 | - | - | N |
| 341334 | 2024 | 2025-02-05 | 522111 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 522110 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 522109 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 522108 | 2024-001 | Significant Deficiency | - | N |
| 341334 | 2024 | 2025-02-05 | 522107 | 2024-001 | Significant Deficiency | - | N |